glp 1 agonists review Mechanisms by which GLP-1 may exert beneficial effects on the GLP1 agonists: current and future

Over recent years, GLP-1-receptor-agonists (GLP-1-RA) have gained significant attention not only for their antidiabetic properties but also for their weight reducing effects [3]

Cagrilintide might also ease some of GLP-1 drugs common gastrointestinal side effects, such as severe nausea and vomiting, says Jesse Richards, an internal medicine and obesity clinician at the University of Oklahoma School of Community Medicine

Social media as pharmacovigilance: the potential for patient reports to inform clinical research on glucagon-like peptide 1 (GLP-1) receptor agonists for substance use disorders

[62]) carried out a phase 1 study with 47 healthy participants without diabetes participants receiving single ascending dose of retatrutide (0.1, 0.3, 1, 3, 4.5, or 6 mg) versus placebo

A Review of practical issues on the use of glucagon-like peptide-1 receptor agonists for the management of type 2 diabetes

Lawrence D, Hancock KJ, Kisely S